← All indications
Weight Loss
Decrease in existing BODY WEIGHT.
Subtype terms (2)
More specific conditions that are subtypes of Weight Loss in the MeSH hierarchy.
- Cachexia
77 drugs (37 approved, 40 experimental)
- Weight Cycling
Drugs by status
Approved for this indication (1)
Phase 4 trials (23)
Phase 3 trials (13)
Phase 2 trials (18)
Phase 1 trials (8)
Other trials (44)
- maltodextrin
- vitamin d3
- orlistat
- beta-hydroxyisovaleric acid
- bifidobacterium animalis
- boron
- calcium citrate
- cocoa bean
- alpha-lipoic acid
- copper
- ethanol
- Hesperedin
- calcium
- ritonavir
- leptin
- levocarnitine
- octreotide
- potassium chloride
- sitagliptin
- glucose
- arabinoxylan
- autologous microbiome
- bifidobacterium longum
- human fecal microbiota
- capsinoid
- cashew apple extract
- coffee
- akkermansia muciniphila
- litramine
- resistant starch
- +14 more
Organizations
Organization Involved with Phase 4 Indications (48)
- Amylin
- Eisai
- Takeda
- Roche
- Novo Nordisk
- Certmedica International GmbH
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Roma La Sapienza
- University of Pennsylvania
- Ain Shams University
- Albany College of Pharmacy and Health Sciences
- Albany Medical College
- Baylor University
- University of London
- Harvard University
- Temple University
- Hospital Juarez de Mexico
- Istituto Auxologico Italiano
- Parker Research Institute
- University of Leicester
- University of Pavia
- Wake Forest University
- Yale University
- Mayo Clinic
- Columbia University
- Tel Aviv University
- University of Connecticut
- University of Copenhagen
- University of Naples Frederico II
- +18 more
Organization Involved with Phase 3 Indications (48)
- Abbott
- AstraZeneca
- Eli Lilly
- Helsinn
- Pfizer
- Sanofi
- Immunotec Inc.
- InovoBiologic Inc.
- InQpharm Group
- Par Pharmaceuticals
- Rottapharm
- Aultman Health Foundation
- National Cancer Institute (NCI)
- Canadian Center for Functional Medicine
- Changi General Hospital
- Loma Linda University
- Mercy Medical Center
- Postgraduate Institute of Medical Education and Research
- Stanford University
- University of South Florida
- University of Toronto
- Fudan University
- University of British Columbia
- analyze & realize GmbH
- Badalona Hospital Germans Trias i Pujol
- Pharmaceutical Research Associates, Inc. (PRA)
- Rovira i Virgili University
- University of Sao Paulo
- University of Barcelona
- St. Elizabeth's Medical Center of Boston
- +18 more
Organization Involved with Phase 2 Indications (75)
- 7TM Pharma A/S
- Celgene
- Genentech
- Anaborex
- Athersys, Inc
- GlaxoSmithKline
- High Point Pharmaceuticals, LLC.
- INC Research
- mdRNA
- NeuroSearch A/S
- Raziel Therapeutics Ltd.
- Solvay
- TTY Biopharm
- Fundació Sant Joan de Déu
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Drug Abuse (NIDA)
- Boston University
- Cathay General Hospital
- Cedars-Sinai Medical Center
- Chang Gung University
- Changhua Christian Hospital
- Chung Shan Medical University
- Chimei Medical Center
- Faculdade de Medicina do ABC
- Emory University
- German Cancer Research Center
- Johns Hopkins University
- Medical College of Wisconsin
- National Cheng Kung University
- +45 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (55)
- Amgen
- Vivus
- Chemical Resources
- Dialpha
- DSM
- Olygose
- National Institute on Aging (NIA)
- United States Department of Agriculture
- Aarhus University
- Duke University
- Gachon University
- Georgetown University
- Greenville Health System
- King George's Medical University
- Medical University of Gdansk
- Nanjing University of Traditional Chinese Medicine
- New York University
- Rutgers University
- Texas A&M University
- Texas Tech University
- University of Glasgow
- University of Kansas
- University of Nebraska
- University of Bath
- University of Bern
- University of Vermont
- Creighton University
- Zhejiang University
- BioTeSys GmbH
- Trinity College Dublin
- +25 more